| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/29/1999 | CA2132936C Stabilized pharmaceutical compositions and stabilizing solvent |
| 06/29/1999 | CA2131722C N,n'-disubstituted amide derivative |
| 06/29/1999 | CA2130275C Use of substituted adenine derivatives for treating multiple sclerosis |
| 06/29/1999 | CA2125974C Senescent cell derived inhibitors of dna synthesis |
| 06/29/1999 | CA2099856C Lactic acid bacterium |
| 06/29/1999 | CA2097823C Therapy for pulmonary vasoconstriction and asthma |
| 06/29/1999 | CA2048200C Polylactide in a purified state, method for the production therof, and pharmaceutical compositions |
| 06/29/1999 | CA2016584C Anthracycline conjugates having a novel linker and methods for their production |
| 06/29/1999 | CA1340616C Process for the biochemical oxidation of steroids and genetically engineered cells to be used therefor |
| 06/29/1999 | CA1340615C Compouds effective in inducing cell differentiation and process for preparing same |
| 06/29/1999 | CA1340614C Cyclopentano-vitamin d analogs |
| 06/26/1999 | CA2256060A1 Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient |
| 06/24/1999 | WO1999031268A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 06/24/1999 | WO1999031262A2 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | WO1999031232A1 Human brain derived kcnq2 potassium channel |
| 06/24/1999 | WO1999031230A2 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | WO1999031141A2 Method for producing regular porous cellulose pearls, corresponding cellulose pearls and use thereof |
| 06/24/1999 | WO1999031140A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 06/24/1999 | WO1999031134A1 Glucose regulated gene |
| 06/24/1999 | WO1999031122A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/24/1999 | WO1999031119A1 Platelet derived growth factor (pdgf) nucleic acid ligand complexes |
| 06/24/1999 | WO1999031112A1 Vitamin d derivatives with phosphorous atoms in the side chains |
| 06/24/1999 | WO1999031110A1 Cephalosporin antibiotics |
| 06/24/1999 | WO1999031105A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | WO1999031104A1 Preparation of 3-substituted adenines and imidazo pyridines |
| 06/24/1999 | WO1999031103A1 Preparation of 3-substituted adenines |
| 06/24/1999 | WO1999031102A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | WO1999031100A1 Novel bispidine antiarrhythmic compounds |
| 06/24/1999 | WO1999031099A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031095A1 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| 06/24/1999 | WO1999031094A1 Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt |
| 06/24/1999 | WO1999031093A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 06/24/1999 | WO1999031092A1 Benzamine derivatives |
| 06/24/1999 | WO1999031090A1 Dihydrobenzofurans |
| 06/24/1999 | WO1999031088A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | WO1999031087A1 Cyclic imide-substituted pyridylalkane, alkene and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031086A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
| 06/24/1999 | WO1999031085A1 3-piperidyl-4-oxoquinazoline derivatives and medicincal compositions containing the same |
| 06/24/1999 | WO1999031078A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 06/24/1999 | WO1999031077A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | WO1999031075A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031068A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/24/1999 | WO1999031067A1 Heterocyclic cytotoxic agents |
| 06/24/1999 | WO1999031066A1 Pyridones as src family sh2 domain inhibitors |
| 06/24/1999 | WO1999031065A1 N-benzyl-3-indenylacetamides derivatives for treating neoplasia |
| 06/24/1999 | WO1999031064A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 06/24/1999 | WO1999031063A1 New piperazinyl-substituted pyridylalkane, alkene and alkine carboxamides |
| 06/24/1999 | WO1999031061A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999031060A2 Piperidinyl-substituted pyridylalkane, alkene and alkine carboxamides as cytostatics and immunesuppressants |
| 06/24/1999 | WO1999031059A1 Potassium channel openers |
| 06/24/1999 | WO1999031058A1 Novel heterocyclic compounds |
| 06/24/1999 | WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 06/24/1999 | WO1999031052A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | WO1999031051A1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 06/24/1999 | WO1999031049A1 Neuroprotective agents |
| 06/24/1999 | WO1999031047A1 Cyclohexene carboxylates as neuraminidase inhibitors |
| 06/24/1999 | WO1999031045A1 Phenylaminoalkylcarboxylic acid derivatives and medicinal compositions containing the same |
| 06/24/1999 | WO1999031037A1 Apoptosis inhibitors |
| 06/24/1999 | WO1999030764A1 Systems and methods for local delivery of an agent |
| 06/24/1999 | WO1999030740A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | WO1999030739A1 Leukemia remedy |
| 06/24/1999 | WO1999030738A2 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | WO1999030733A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | WO1999030722A1 Pharmaceutical compositions for mucolysis and treatment of inflammation |
| 06/24/1999 | WO1999030721A1 Cyclooxygenase-2 inhibition |
| 06/24/1999 | WO1999030720A1 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 06/24/1999 | WO1999030719A2 Use of an oestrogen for treating postnatal depression |
| 06/24/1999 | WO1999030718A2 PROSTAGLANDIN E2/F2α COMBINATION FOR TREATING IMPOTENCE AND ENHANCING SEXUAL AROUSAL |
| 06/24/1999 | WO1999030717A1 Use of brinzolamide for the manufacture of a medicament for improving ocular blood flow |
| 06/24/1999 | WO1999030716A1 The use of nitric oxide generations for the treatment of dry eye disorders |
| 06/24/1999 | WO1999030715A1 Preventives/remedies for sleep disturbance |
| 06/24/1999 | WO1999030714A1 Sustained-release theophylline preparation and process for producing the same |
| 06/24/1999 | WO1999030713A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030712A1 Agents |
| 06/24/1999 | WO1999030711A1 Drugs augmenting nkt cells |
| 06/24/1999 | WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 06/24/1999 | WO1999030709A1 Integrin receptor antagonists |
| 06/24/1999 | WO1999030708A2 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | WO1999030707A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 06/24/1999 | WO1999030706A1 ANTIHYPERLIPIDEMIC STATIN-LP(a) INHIBITOR COMBINATIONS |
| 06/24/1999 | WO1999030705A1 Reduction of uv induced skin cancer by topical amines |
| 06/24/1999 | WO1999030704A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways |
| 06/24/1999 | WO1999030702A1 Percutaneously absorbable levodopa-containing preparation |
| 06/24/1999 | WO1999030701A1 Method of the prophylactic treatment of mastitis |
| 06/24/1999 | WO1999030699A1 Modulators of cysteine protease |
| 06/24/1999 | WO1999030698A1 A drug for treating diabetic nephrosis and delaying renal failure |
| 06/24/1999 | WO1999030697A2 Combination effective for the treatment of impotence |
| 06/24/1999 | WO1999030696A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | WO1999030695A1 Substituted amidino compounds in the treatment of chronic obstructive pulmonary disease |
| 06/24/1999 | WO1999030694A2 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |
| 06/24/1999 | WO1999030693A2 A double capsule for the administration of active principles in multiple therapies |
| 06/24/1999 | WO1999030692A1 IMPROVED HMG CoA REDUCTASE INHIBITOR EXTENDED RELEASE FORMULATION |
| 06/24/1999 | WO1999030687A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | WO1999030684A1 Local delivery of therapeutic agents |
| 06/24/1999 | WO1999030682A1 Novel antioxidant mixture |
| 06/24/1999 | WO1999030675A1 Methods for improving the health of hair and scalp |
| 06/24/1999 | WO1999030562A1 Method for treating fibroproliferative disorders by inhibitors of protein hydroxylation |
| 06/24/1999 | WO1999030560A1 Transdermal therapeutic device and method with capsaicin and capsaicin analogs |